Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.
Viron, Inc. has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2022.
Viron, Inc. is headquartered in Boston, United States.
Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.
Viron, Inc. is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Viron, Inc. — Funding & Investors." VCBacked, June 23, 2022, https://www.vcbacked.co/company/viron-inc. Accessed August 14, 2026.
VCBacked. (2022). Viron, Inc. — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/viron-inc
{{cite web |title=Viron, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/viron-inc |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated